Quality care in seniors with new-onset rheumatoid arthritis: A canadian perspective

Arthritis Care and Research

Volumn 63, Issue 1, 2011, Pages 53-57

  Widdifield, Jessica ^a   Bernatsky, Sasha ^b,f   Paterson, J Michael ^a,c   Thorne, J Carter ^d   Cividino, Alfred ^c   Pope, Janet ^e   Gunraj, Nadia ^a   Bombardier, Claire ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

^e St Joseph Health Care   (Canada)

^f MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; SALAZOSULFAPYRIDINE; ANTIRHEUMATIC AGENT;

AGED; ARTICLE; CANADA; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEW ONSET RHEUMATOID ARTHRITIS; PATIENT CARE; PHARMACY; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; COHORT ANALYSIS; COMPARATIVE STUDY; ONSET AGE; STANDARD;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COHORT STUDIES; FEMALE; HUMANS; MALE; ONTARIO; QUALITY OF HEALTH CARE;

EID: 79551530608     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20304     Document Type: Article

References (19)

1. Tsakonas E, Fitzgerald A, Fitzcharles MA, Cividino A, Thorne JC, Seffar AM, et al, for the HERA Study Group. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3-year follow-up on the Hydroxychloroquine in Early Rheumatoid Arthritis (HERA) study. J Rheumatol 2000; 27:623-9. (Pubitemid 30151337)
2. Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic diseasemodifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59:762-84. (Pubitemid 351847559)
3. Bukhari M, Lunt M, Barton A, Bunn D, Silman A, Symmons D. Increasing age at symptom onset is associated with worse radiological damage at presentation in patients with early inflammatory polyarthritis. Ann Rheum Dis 2007;66:389-93. (Pubitemid 46579642)
4. Calvo-Alen J, Corrales A, Sanchez-Andrada S, Fernandez- Echevarria MA, Pena JL, Rodriguez-Valverde V. Outcome of late-onset rheumatoid arthritis. Clin Rheumatol 2005;24: 485-9. (Pubitemid 43055039)
5. Tutuncu Z, Reed G, Kremer J, Kavanaugh A. Do patients with older-onset rheumatoid arthritis receive less aggressive treatment? Ann Rheum Dis 2006;65:1226-9. (Pubitemid 44277402)
6. MacLean CH, Louie R, Leake B, McCaffrey DF, Paulus HE, Brook RH, et al. Quality of care for patients with rheumatoid arthritis. J Am Med Assoc 2000;284:984-92. (Pubitemid 30662053)
7. Bernatsky S, Hudson M, Suissa S. Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology (Oxford) 2007;46:1157-60. (Pubitemid 47050621)
8. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
9. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 2004; 57:1288-94. (Pubitemid 40023149)
10. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001;154:854-64. (Pubitemid 33000813)
11. Bykerk VP, Baron M, Boire G, Haraoui B, Khraishi M, LeClercq S, et al. Canadian consensus statement on early optimal therapy in early rheumatoid arthritis. CRA J 2004;14: 11-3. URL: http://www.rheum.ca/Resources/Pdf/ERA.pdf.
12. Feldman D, Bernatsky S, Haggerty J, Leffondre K, Tousignant P, Roy Y, et al. Delay in consultation with specialists for persons with suspected new-onset rheumatoid arthritis: a population-based study. Arthritis Rheum 2007;57:1419-25. (Pubitemid 350308839)
13. Lacaille D, Anis AH, Guh DP, Esdaile JM. Gaps in care for rheumatoid arthritis: a population study. Arthritis Rheum 2005;53:241-8. (Pubitemid 40530165)
14. Shipton D, Glazier R, Guan J, Badley EM. Effects of use of specialty services on disease-modifying antirheumatic drug use in the treatment of rheumatoid arthritis in an insured elderly population. Med Care 2004;42:907-13. (Pubitemid 39456923)
15. Bernatsky S, Ehrmann Feldman D. Discontinuation of methotrexate therapy in older patients with newly diagnosed rheumatoid arthritis: analysis of administrative health databases in Quebec, Canada. Drugs Aging 2008;25:879-84.
16. Carli C, Bridges JF, Ask J, Lindblad S, for the Swedish Rheumatoid Arthritis Register. Charting the possible impact of national guidelines on the management of rheumatoid arthritis. Scand J Rheumatol 2008;37:188-93. (Pubitemid 351874002)
17. American College of Rheumatology and The Health Care Group Inc. Practice benchmarking for the rheumatologist: report of results 2003 survey. 2003. URL: http://www.rheumatology.org/practice/office/benchmarking/.
18. Badley E, Veinot P, Ansari H, Mackay C, Thorne C, and the Arthritis Community Research and Evaluation Unit, University Health Network. 2007 survey of rheumatologists in Ontario: July 2008. URL: http://www.acreu.ca/pdf/pub5/08- 03.pdf.
19. Tiippana-Kinnunen T, Paimela L, Kautiainen H, Laasonen L, Leirisalo-Repo M. Can disease-modifying anti-rheumatic drugs be discontinued in long-standing rheumatoid arthritis? A 15-year follow-up. Scand J Rheumatol 2010;39:12-8.